In India, about 241 million children between the ages of 1 and 14 are susceptible to parasitic intestinal worms.

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with ...

Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx ...

University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

Abcuro Inc. has raised a $200 million Series C financing to fund late-stage development and support commercial launch ...

Maple Grove-based Morari Medical’s device “MOR” is a drug- and chemical-free approach for the common men’s sexual health ...

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...

Drugs for metabolic diseases, vaccines, and cancer therapies feature among new product launches this year that could top $1 billion in annual sales or be clinical "game changers" in the next five ...

Emblaveo is a fixed-dose IV treatment that combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.

The tablet formulation can either be swallowed whole or dispersed in a teaspoon of filtered (non-chlorinated) water.